Gf Fund Management Co. Ltd. Rhythm Pharmaceuticals, Inc. Call Options Transaction History
Gf Fund Management Co. Ltd.
- $4.62 Trillion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RYTM
# of Institutions
214Shares Held
64.4MCall Options Held
445KPut Options Held
26.6K-
Black Rock Inc. New York, NY6.74MShares$378 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA6.57MShares$368 Million0.29% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.08MShares$341 Million5.51% of portfolio
-
Baker Bros. Advisors LP New York, NY6.08MShares$341 Million3.77% of portfolio
-
Perceptive Advisors LLC New York, NY3.68MShares$206 Million6.86% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $3.12B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...